Dr. Daniel A. Vallera is a professor in the Department of Radiation Oncology and an established member of the Masonic Cancer Center, University of Minnesota. He received his PhD at Ohio State University in 1978 and was appointed to the faculty of the University of Minnesota in 1982. His interests in cancer immunology have varied over the years and include leukemia, graft-versus-leukemia, targeted antibody therapy, immunoconjugates, veterinary oncology studies in dogs, and more recently bispecific antibodies and TriKEs. He is an inventor on multiple patents and has invented genetically engineered drugs that have been tested in humans.